This book has been replaced by Treating Alcohol and Drug Problems in Psychotherapy Practice, Second Edition, ISBN 978-1-4625-5086-9.

Evidence-Based Treatments for Alcohol and Drug Abuse encompasses the developments in the field over the last decade, blending theory, techniques and clinical flexibility. Research in the past decade has shown that substance abuse and substance dependence are treatable. The field has witnessed the introduction of evidence-based psychological and specific pharmacological treatments. Unfortunately, many of the empirical supported therapies for addictions are still not widely applied by practitioners. The third volume in the Practical Clinical Guidebooks Series (PCG), Evidence-Based Treatments for Alcohol and Drug Abuse, defines the characteristics, classification, and prevalence of substance use disorders, and provides the clinician with practical guidelines applicable across a variety of treatment settings and patient groups. Drawing on the recent research in the field, the authors provide the practicing clinician and student with an up-to-date understanding of the epidemiology, etiology, course and prognosis of substance abuse disorders that would be relevant to clinical practice. In addition to describing phenomenology and etiology, the book provides a comprehensive guide to the assessment and treatment of DSM-IV-TR substance abuse disorders (SUDs), including abuse and dependence of alcohol, stimulants, opiates, hallucinogens, cannabis/marijuana, sedative, and party drugs.

Presents the Brown University/Providence VA treatment program for addictive behaviors. The principles are presented in specific step-by-step detail. Cloth edition ($35.00) not seen. Annotation copyright Book News, Inc. Portland, Or.

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.

"Providing a framework for treating substance use disorders (SUDs) in office-based psychotherapy, the second edition of this trusted work has been updated throughout and features two entirely new chapters. The authors show how clinicians from any background can leverage the therapeutic skills they already have to address clients' alcohol and drug problems competently and effectively. Vivid case examples demonstrate ways to engage clients at different stages of change; set collaborative treatment goals; address SUDs concurrently with other psychological problems; and interweave motivational, cognitive-behavioral, and other interventions, tailored to each individual's needs. Reproducible forms and handouts can be downloaded and printed in a convenient 8 1/2" x 11" size. Subject areas/key words: substance use disorders, SUDs, psychotherapists, counselors, counseling clients with, patients, addictions, addictive behavior, abuse, harm reduction, nonspecialists, treatments, practical guide, alcoholism, in recovery, drinking, and opioids. Clinical audience: clinical psychologists, psychiatrists, clinical social workers, mental health counselors, and psychiatric nurses"--

This volume reviews a range of empirically supported approaches to prevention and treatment of adolescent substance use problems. The focus is on motivationally based brief interventions that can be delivered in a variety of contexts, that address key developmental considerations, and that draw on cutting-edge knowledge on addictive behavior change. From expert contributors, coverage encompasses alcohol skills training; integrative behavioral and family therapy; motivational interviewing; interventions for dually diagnosed youth; Internet-based education, prevention, and treatment; and applications to HIV prevention. The volume is extensively referenced and includes numerous clinical illustrations and vignettes.

What are the most promising strategies to treat alcohol and drug abuse? What are their medical implications? Despite the enormous resources spent on treating alcoholism and drug dependence, there is still no satisfactory evaluation of their effectiveness or of the cost of the different alternatives. Programs designed to treat substance abuse should be built on a foundation of evidence-based knowledge. Yet it is almost impossible to cope with the increasing amount of scientific literature. This book thus represents a guide through the myriads of articles. The most comprehensive scientific review of its kind, it presents the findings from more than 1,600 studies on the effectiveness of different treatments. The work also includes a summary of the methods available to intervene against harmful levels of alcohol, with most of the studies making use of the Diagnostic and Statistical Manual of Mental Disorders (DSM) system. The extensive results are arranged in detailed tables, which may be searched using the accompanying CD-ROM. Also enclosed are a quality checklist and an extensive glossary explaining more than 70 terms. An invaluable tool for medical researchers, clinicians and doctors as well as healthcare providers and insurers, allowing them to save major resources by identifying ineffective treatments and being aware of cost-effective alternatives. With a foreword by Henry R. Kranzler, University of Connecticut, USA.